Skip to content

Drug interactions

Quizartinib + Sotalol

Severity: Major

Quizartinib and Sotalol: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs prolong the QT interval, and the combination increases the risk of torsades de pointes. Quizartinib labeling advises avoiding other QT-prolonging drugs where possible.

What this interaction means in plain words

Quizartinib and Sotalol can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Quizartinib belongs to Oncology; Sotalol belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Additive QTc prolongation.

What to do

Avoid the combination if possible; if unavoidable, do frequent ECG monitoring, keep potassium and magnesium normal, and reduce the quizartinib dose or interrupt it if QTc becomes prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Quizartinib and Sotalol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Quizartinib with Sotalol?

MediHelp rates the interaction as major. Quizartinib and Sotalol can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs prolong the QT interval, and the combination increases the risk of torsades de pointes. Quizartinib labeling advises avoiding other QT-prolonging drugs where possible.

How serious is the interaction between Quizartinib and Sotalol?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible; if unavoidable, do frequent ECG monitoring, keep potassium and magnesium normal, and reduce the quizartinib dose or interrupt it if QTc becomes prolonged.

What other medicines interact with Sotalol?

MediHelp also lists interactions of Sotalol with, for example, Arsenic trioxide, Artemether / lumefantrine, Disopyramide. The full list is on the Sotalol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in